Niraparib in Patients With Pancreatic Cancer

• Status: Recruiting
• Trial end date: 2025-02-28

Summary

This research study is studying an investigational therapy as a possible treatment for pancreatic cancer.

The drugs involved in this study are:

-Niraparib

• Phase: Phase 2

Details

• Lead Sponsor: Dana-Farber Cancer Institute
• Collaborator: Tesaro, Inc.
• Treatments: Niraparib